citalopram overdose

1
Reactions 1044 - 26 Mar 2005 O S Citalopram overdose First report of junctional bradycardia treated with sodium bicarbonate in an elderly patient: case report An 82-year-old woman developed junctional bradycardia after intentional ingestion of a citalopram overdose; bradycardia was reversed following treatment with IV sodium bicarbonate. The woman, who had a history of depression, was discovered 12 hours after ingesting citalopram 1.6g in a suicide attempt. A generalised tonic-clonic seizure was witnessed and, on admission, she was postictal, with a BP of 148/66mm Hg, a HR of 61 beats/min, a respiratory rate of 20 breaths/min and a temperature of 36.2°C. Her Mini-Mental State Examination score was 22, and an ECG showed sinus bradycardia, a ventricular rate of 58 beats/min, left axis deviation and left bundle branch block, consistent with previous ECGs. Her QRS duration and QT and QTc intervals were 146, 544 and 534 msec, respectively. Laboratory investigations revealed a serum citalopram concentration of 910 ng/mL (therapeutic range 120 ng/mL). She became increasingly alert over the next 3 hours and was transferred for monitoring of her prolonged QT-QTc intervals. Three hours later, she developed marked bradycardia and an ECG showed a junctional escape rhythm, a ventricular rate of 40 beats/min, retrograde ventriculoatrial activation and underlying left bundle branch block. Her QRS duration increased to 152 msec and her QT and QTc intervals increased to 646 and 527 msec, respectively. The woman received a sodium bicarbonate 50 mEq injection (50mL of an 8.4% solution) and, within 5 minutes, her QRS duration decreased to 142 msec. There was prompt conversion to a nonsinus atrial rhythm, with a ventricular rate of 80 beats/min and a normal PR interval. These changes lasted for approximately 3 minutes before reverting to junctional bradycardia. She received a second sodium bicarbonate injection, with a similar transient effect. A continuous infusion of sodium bicarbonate 150 mEq in 1L of 5% dextrose was started and, within 3 hours, normal sinus rhythm returned, with a HR of 63 beats/min and QT and QTc intervals of 510 and 504 msec, respectively. The infusion was stopped after 36 hours, without recurrence of the ECG abnormalities. Brucculeri M, et al. Reversal of citalopram-induced junctional bradycardia with intravenous sodium bicarbonate. Pharmacotherapy 25: 119-122, No. 1, Jan 2005 - USA 801001501 » Editorial comment: A search of AdisBase and Medline did not reveal any previous case reports of junctional bradycardia associated with citalopram. The WHO Adverse Drug Reactions database contained 76 reports of bradycardia associated with citalopram. 1 Reactions 26 Mar 2005 No. 1044 0114-9954/10/1044-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: trinhbao

Post on 18-Mar-2017

222 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Citalopram overdose

Reactions 1044 - 26 Mar 2005

★ O SCitalopram overdose

First report of junctional bradycardia treated withsodium bicarbonate in an elderly patient: casereport

An 82-year-old woman developed junctional bradycardiaafter intentional ingestion of a citalopram overdose;bradycardia was reversed following treatment with IV sodiumbicarbonate.

The woman, who had a history of depression, wasdiscovered 12 hours after ingesting citalopram 1.6g in asuicide attempt. A generalised tonic-clonic seizure waswitnessed and, on admission, she was postictal, with a BP of148/66mm Hg, a HR of 61 beats/min, a respiratory rate of20 breaths/min and a temperature of 36.2°C. Her Mini-MentalState Examination score was 22, and an ECG showed sinusbradycardia, a ventricular rate of 58 beats/min, left axisdeviation and left bundle branch block, consistent withprevious ECGs. Her QRS duration and QT and QTc intervalswere 146, 544 and 534 msec, respectively. Laboratoryinvestigations revealed a serum citalopram concentration of910 ng/mL (therapeutic range ≤ 120 ng/mL). She becameincreasingly alert over the next 3 hours and was transferred formonitoring of her prolonged QT-QTc intervals. Three hourslater, she developed marked bradycardia and an ECG showeda junctional escape rhythm, a ventricular rate of 40 beats/min,retrograde ventriculoatrial activation and underlying leftbundle branch block. Her QRS duration increased to 152 msecand her QT and QTc intervals increased to 646 and 527 msec,respectively.

The woman received a sodium bicarbonate 50 mEq injection(50mL of an 8.4% solution) and, within 5 minutes, her QRSduration decreased to 142 msec. There was promptconversion to a nonsinus atrial rhythm, with a ventricular rateof 80 beats/min and a normal PR interval. These changes lastedfor approximately 3 minutes before reverting to junctionalbradycardia. She received a second sodium bicarbonateinjection, with a similar transient effect. A continuous infusionof sodium bicarbonate 150 mEq in 1L of 5% dextrose wasstarted and, within 3 hours, normal sinus rhythm returned,with a HR of 63 beats/min and QT and QTc intervals of 510and 504 msec, respectively. The infusion was stopped after36 hours, without recurrence of the ECG abnormalities.Brucculeri M, et al. Reversal of citalopram-induced junctional bradycardia withintravenous sodium bicarbonate. Pharmacotherapy 25: 119-122, No. 1, Jan 2005 -USA 801001501

» Editorial comment: A search of AdisBase and Medline didnot reveal any previous case reports of junctional bradycardiaassociated with citalopram. The WHO Adverse Drug Reactionsdatabase contained 76 reports of bradycardia associated withcitalopram.

1

Reactions 26 Mar 2005 No. 10440114-9954/10/1044-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved